Early-career researchers in the time of COVID-19: Benefits of structural support.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 33961768.
- Also identified by DOI 10.1016/j.stem.2021.04.022 and PMC identifier 8101064.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
COVID-19 shutdowns have had detrimental impacts on new labs, but thoughtful support from institutions and funding bodies may alleviate key pressures and stresses compounded by forced decreases in productivity. Here, Cell Stem Cell chats with two investigators from our "Introductions to the community: Early-career researchers in the time of COVID-19" Voices series about support they've received from their institutions and funders.
Medical subject headings
- COVID-19